Clinical Trials
44
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials
Glycemic Metrics and Patterns in People With and Without Prediabetes
- Conditions
- Pre Diabetes
- First Posted Date
- 2025-04-10
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Abbott Diabetes Care
- Target Recruit Count
- 2000
- Registration Number
- NCT06921902
- Locations
- 🇺🇸
Diabetes and Obesity Care, Bend, Oregon, United States
Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring
- Conditions
- Diabetes Mellitus
- First Posted Date
- 2024-11-01
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Abbott Diabetes Care
- Target Recruit Count
- 800
- Registration Number
- NCT06668935
- Locations
- 🇺🇸
East Coast Institute for Research, LLC, Jacksonville, Florida, United States
🇺🇸Excellence Medical and Research, Miami Gardens, Florida, United States
Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated With Basal Insulin in Finland
- Conditions
- Type 2 Diabetes Treated With Insulin
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2024-05-10
- Lead Sponsor
- Abbott Diabetes Care
- Target Recruit Count
- 82
- Registration Number
- NCT06268821
- Locations
- 🇫🇮
Pihlajalinna Jämsä, Välikatu 1,, Jämsä, Finland
🇫🇮Pihlajalinna Koskiklinikka, Hatanpäänvaltatie 1,, Tampere, Finland
Initiation of Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin, in Italy
- Conditions
- Type 2 Diabetes Treated With Insulin
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- Abbott Diabetes Care
- Target Recruit Count
- 82
- Registration Number
- NCT06268808
- Locations
- 🇮🇹
ASL Toscana Nordovest, Carrara, Italy
🇮🇹Azienda Ospedaliero- Universitaria "Renato Dulbecco" di Catanzaro, Catanzaro, Italy
🇮🇹Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari, Bari, Italy
FreeStyle Libre 3 Continuous Glucose Monitoring System
- Conditions
- Diabetes Mellitus
- First Posted Date
- 2023-07-27
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Abbott Diabetes Care
- Target Recruit Count
- 7
- Registration Number
- NCT05962710
- Locations
- 🇺🇸
Sansum Diabetes Research Institute, Santa Barbara, California, United States
🇺🇸Rocky Mountain Diabetes & Osteoporosis Center, Idaho Falls, Idaho, United States
🇺🇸Diabetes and Glandular Disease Clinic, San Antonio, Texas, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
News
Federal Circuit Upholds Patent Cancellation for DexCom Glucose Monitor Sensor Technology
The Federal Circuit upheld the Patent Trial and Appeal Board's decision to cancel six claims from DexCom's US Patent No. 10,702,193 covering implantable glucose monitoring sensors.
Once-Weekly Insulin Icodec Combined with CGM Shows Promising Results for Type 2 Diabetes Management
Adults with type 2 diabetes achieved significant HbA1c reduction from 8.18% to 7% over 26 weeks using once-weekly insulin icodec combined with continuous glucose monitoring in the ONWARDS 9 trial.